Latest Breaking News On - World muscle society - Page 1 : comparemela.com

Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoLinda marbLos angelesExchange commissionNs pharma incCapricor therapeutics incWorld muscle societyDivision of microbiologyHuman servicesInternational annual congressExosome programGlobenewswire incCapricor company contactUs department of healthNational institutes of health

Edgewise Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

– Overenrolled CANYON and advanced the global pivotal cohort, GRAND CANYON, of EDG-5506 in Becker muscular dystrophy – – Advanced Phase 2 LYNX trial of EDG-5506 including new cohort for boys.

United statesKevin kochDuchenne beckerAmerican heart association scientific sessionsSociety annual scientific sessionsUs food drug administrationSecurities exchangeExchange commissionCardiovascular programEdgewise therapeutics incWorld muscle societyMusculoskeletal programEdgewise therapeuticsChief executive officerNorth star ambulatory assessmentFast track

Scholar Rock Provides Corporate Update and Highlights Priorities for 2024

- Advancing industry-leading antimyostatin pipeline, comprised of multiple, novel assets with unparalleled selectivity, to treat spinal muscular atrophy and cardiometabolic disorders - Completed.

British columbiaTed mylesJay backstromExchange commissionScholar rock incScholar rockChief executive officerKeystone symposiaClinical care meetingAnnual congressWorld muscle societyAnnual meetingChief operating officerChief financialHealthcare conference presentationHealthcare conference

After Elevidys: DMD Advocacy Past First Gene Therapy Approval

For This Year in Medicine, CGTLive looks back at a landmark first approval, the new treatment opportunities it has provided, and the unmet needs in the field it has brought to light.

Sharon hesterleeMichael kellyJeffrey chamberlainUniversity of washington school medicineWorld muscle societyMuscular dystrophy associationInternational congressSarepta therapeuticNorth star ambulatory assessmentParent project muscular dystrophyMuscular dystrophy specialized research centerWashington schoolCapricor therapeuticFirst gene therapyTreat duchenne muscularAnnual international congress

Capricor Therapeutics, Inc (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor’s Third Quarter 2023 Financial Results and Corporate Update Call. This conference call is being recorded.

San diegoUnited statesLinda marbJoe pantginisAydin huseynovMichael kelliherWorld muscle society conferenceCapricor therapeutics incBusiness development at horizon therapeuticsGroup viceCapricor therapeuticsCall transcript novemberThird quarterCorporate updateChief financialDuchenne muscular